New York Life Investment Management LLC Regeneron Pharmaceuticals, Inc. Transaction History
New York Life Investment Management LLC
- $9.63 Billion
- Q3 2024
A detailed history of New York Life Investment Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, New York Life Investment Management LLC holds 14,249 shares of REGN stock, worth $9.93 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
14,249
Previous 14,656
2.78%
Holding current value
$9.93 Million
Previous $15.4 Million
2.75%
% of portfolio
0.16%
Previous 0.16%
Shares
10 transactions
Others Institutions Holding REGN
# of Institutions
1,529Shares Held
82.7MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.5 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.89 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.22 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.42 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...